The journal welcomes submissions across the following sections:

• Cell Structure and Function — Organelle biology, membrane systems, cytoskeleton, and subcellular architecture
• Cell Signaling and Transduction — Signalling pathways, receptor biology, and intracellular communication
• Cell Cycle and Proliferation — Cell division, mitosis, meiosis, and growth regulation
• Cell Differentiation and Development — Stem cells, lineage commitment, and developmental cell biology
• Cell Death and Apoptosis — Programmed cell death, autophagy, necroptosis, and senescence
• Cell Metabolism — Cellular bioenergetics, metabolic regulation, and metabolic disease
• Cell–Environment Interactions — Mechanobiology, extracellular matrix, microenvironment, and stress responses
• Cell Engineering and Technology — Synthetic biology, gene editing, cell reprogramming, and emerging cellular tools
• Cell Disease Models — Cellular models of human disease, organoids, and in vitro disease systems
• Clinical and Translational Research — Cell-based therapies, biomarkers, and translational cell biology
• Traditional and Complementary Medicine — Cellular and molecular mechanisms of traditional and complementary therapies

• Original Research — Empirical studies reporting novel findings
• Systematic Review & Meta-Analysis — Rigorous synthesis of existing evidence
• Methods & Protocols — Novel experimental techniques, assays, or tools with validation
• Short Communication — Concise reports of significant preliminary findings
• Perspective & Commentary — Expert views on emerging topics or field developments
• Review Article — Comprehensive overviews of established or emerging research areas

All submissions undergo single-anonymous peer review conducted by at least two independent domain experts. The editorial board is committed to transparent, constructive, and timely review — target first decision within 6 weeks of submission.

Cell Conflux adheres to the COPE (Committee on Publication Ethics) guidelines and requires all research involving animal or human subjects to comply with applicable ethical standards and relevant reporting guidelines (ARRIVE, MIAME, etc.).